These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 7944532

  • 1. Relationship of endocrinopathy to iron chelation status in young patients with thalassaemia major.
    Grundy RG, Woods KA, Savage MO, Evans JP.
    Arch Dis Child; 1994 Aug; 71(2):128-32. PubMed ID: 7944532
    [Abstract] [Full Text] [Related]

  • 2. Mild subclinical hypothyroidism in thalassaemia major: prevalence, multigated radionuclide test, clinical and laboratory long-term follow-up study.
    De Sanctis V, De Sanctis E, Ricchieri P, Gubellini E, Gilli G, Gamberini MR.
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():174-80. PubMed ID: 19337174
    [Abstract] [Full Text] [Related]

  • 3. Prevalence of growth and puberty failure with respect to growth hormone and gonadotropins secretion in beta-thalassemia major.
    Moayeri H, Oloomi Z.
    Arch Iran Med; 2006 Oct; 9(4):329-34. PubMed ID: 17061604
    [Abstract] [Full Text] [Related]

  • 4. Management of puberty for optimal auxological results in beta-thalassaemia major.
    Caruso-Nicoletti M, De Sanctis V, Cavallo L, Raiola G, Ruggiero L, Skordis N, Wonke B, International Workshop on Management of Puberty for Optimum Auxological Results.
    J Pediatr Endocrinol Metab; 2001 Jul; 14 Suppl 2():939-44. PubMed ID: 11529399
    [Abstract] [Full Text] [Related]

  • 5. Endocrinopathies in adolescents with thalassaemia major receiving oral iron chelation therapy.
    Sharma R, Seth A, Chandra J, Gohain S, Kapoor S, Singh P, Pemde H.
    Paediatr Int Child Health; 2016 Feb; 36(1):22-7. PubMed ID: 25311879
    [Abstract] [Full Text] [Related]

  • 6. Growth and management of short stature in thalassaemia major.
    Theodoridis C, Ladis V, Papatheodorou A, Berdousi H, Palamidou F, Evagelopoulou C, Athanassaki K, Konstantoura O, Kattamis C.
    J Pediatr Endocrinol Metab; 1998 Feb; 11 Suppl 3():835-44. PubMed ID: 10091154
    [Abstract] [Full Text] [Related]

  • 7. Thyroid function in thalassaemia major.
    Senanayake MP, Suraweera SA, Hubert HD.
    Ceylon Med J; 1999 Dec; 44(4):166-8. PubMed ID: 10895267
    [Abstract] [Full Text] [Related]

  • 8. Growth and puberty and its management in thalassaemia.
    De Sanctis V.
    Horm Res; 2002 Dec; 58 Suppl 1():72-9. PubMed ID: 12373018
    [Abstract] [Full Text] [Related]

  • 9. Prevalence of endocrine complications and short stature in patients with thalassaemia major: a multicenter study by the Thalassaemia International Federation (TIF).
    De Sanctis V, Eleftheriou A, Malaventura C, Thalassaemia International Federation Study Group on Growth and Endocrine Complications in Thalassaemia.
    Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():249-55. PubMed ID: 16462705
    [Abstract] [Full Text] [Related]

  • 10. Endocrine complications in patients with Thalassaemia Major.
    Toumba M, Sergis A, Kanaris C, Skordis N.
    Pediatr Endocrinol Rev; 2007 Dec; 5(2):642-8. PubMed ID: 18084158
    [Abstract] [Full Text] [Related]

  • 11. Hormonal changes in thalassaemia major.
    Flynn DM, Fairney A, Jackson D, Clayton BE.
    Arch Dis Child; 1976 Nov; 51(11):828-36. PubMed ID: 1008588
    [Abstract] [Full Text] [Related]

  • 12. Effect of different treatment regimes on linear growth and final height in beta-thalassaemia major.
    De Sanctis V, Katz M, Vullo C, Bagni B, Ughi M, Wonke B.
    Clin Endocrinol (Oxf); 1994 Jun; 40(6):791-8. PubMed ID: 8033371
    [Abstract] [Full Text] [Related]

  • 13. Insulin and glucagon responses to provocation with glucose and arginine in prepubertal children with thalassemia major before and after long-term blood transfusion.
    Soliman AT, el Banna N, alSalmi I, Asfour M.
    J Trop Pediatr; 1996 Oct; 42(5):291-6. PubMed ID: 8936961
    [Abstract] [Full Text] [Related]

  • 14. Assessment of thyroid function in two hundred patients with beta-thalassemia major.
    Zervas A, Katopodi A, Protonotariou A, Livadas S, Karagiorga M, Politis C, Tolis G.
    Thyroid; 2002 Feb; 12(2):151-4. PubMed ID: 11916284
    [Abstract] [Full Text] [Related]

  • 15. Growth, puberty and endocrine function in beta-thalassaemia major.
    Low LC.
    J Pediatr Endocrinol Metab; 1997 Feb; 10(2):175-84. PubMed ID: 9364350
    [Abstract] [Full Text] [Related]

  • 16. Growth and endocrine function in thalassemia major in childhood and adolescence.
    Delvecchio M, Cavallo L.
    J Endocrinol Invest; 2010 Jan; 33(1):61-8. PubMed ID: 20203539
    [Abstract] [Full Text] [Related]

  • 17. Effect of iron overload on endocrinopathies in patients with beta-thalassaemia major and intermedia.
    Kurtoglu AU, Kurtoglu E, Temizkan AK.
    Endokrynol Pol; 2012 Jan; 63(4):260-3. PubMed ID: 22933160
    [Abstract] [Full Text] [Related]

  • 18. Exaggerated TSH response to TRH ("sub-biochemical" hypothyroidism) in prepubertal and adolescent thalassaemic patients with iron overload: prevalence and 20-year natural history.
    De Sanctis V, Tanas R, Gamberini MR, Sprocati M, Govoni MR, Marsella M.
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():170-3. PubMed ID: 19337173
    [Abstract] [Full Text] [Related]

  • 19. Thyroid function in children with beta-thalassemia major in north Jordan.
    al-Hader A, Bashir N, Hasan Z, Khatib S.
    J Trop Pediatr; 1993 Apr; 39(2):107-10. PubMed ID: 8492359
    [Abstract] [Full Text] [Related]

  • 20. Iron-endocrine pattern in patients with beta-thalassaemia.
    el-Hazmi MA, Warsy AS, al-Fawaz I.
    J Trop Pediatr; 1994 Aug; 40(4):219-24. PubMed ID: 7932935
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.